UM  > 中華醫藥研究院
DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY PHARMACIES IN CHINA: AN ANALYSIS OF CHEMICAL DRUGS
Lai, YF1; Chen, SQ2; Chen, PH2; Chen, XW1; Ung, COL1; Hu, H1
2019
Source PublicationVALUE IN HEALTH
ISSN1098-3015
Volume22Issue:2Pages:S175-S175
Abstract

Objectives

This study aimed to explore the situation of chemical drugs used for patients with respiratory disease at community pharmacies in China.

Methods

Using the data from the China Health Industry Intelligence System Database from 2014 to 2017, which collected data from community pharmacies (n = 11,450) in 185 cities over China. Comprehensive analysis of the utilization of chemical drugs in respiratory disease in community pharmacies from the perspectives of market share, indications, and prescription.

Results

The sales of chemical drugs in the community pharmacies raised from 11.4 billion yuan in 2014 to 13.9 billion yuan in 2017 with the compound annual growth rate is 6.58%. The market share of prescription drugs increased from 24.99% in 2014 to 32.20% in 2017.The market concentration rate of chemical drugs is gradually decreasing, which the concentration of TOP10 reduced from 51.53% in 2014 to 47.64% in 2017. The nature of prescriptions and indication of the Top 10 chemical drugs in 2017 were: (1)Pediatric paracetamol, atificial cow-bezoar and chlorphenamine maleate granules(OTC, cold); (2)Compound paracetamol capsule(OTC, cold); (3) Compound paracetamol tablets(OTC, cold); (4)Pediatric paracetamol granules(OTC, cold); (5)Loratadine tablets(OTC, allergic rhinitis); (6)Salmeterol xinafoate and fluticasone propionate powder for inhalation(prescription ,asthma); (7)Montelukast sodium chewable tablets(prescription, asthma); (8) Ambroxol hydrochloride and clenbuterol hydrochloride oral solution(prescription, bronchitis); (9)Ibuprofen suspension(OTC, cold), (10)Budesonide formoterol powder inhalation(prescription, asthma).

Conclusions

At community pharmacies in China, the chemical drugs for patients with respiratory disease, especially the OTC, are mainly used to treat colds, and the prescription drugs for asthma treatment increase rapidly. More interventions are needed to enhance drug therapy management of respiratory disease.

DOI10.1016/j.jval.2019.04.753
Indexed BySCI
Language英语
WOS Research AreaBusiness & Economics ; Health Care Sciences & Services
WOS SubjectEconomics ; Health Care Sciences & Services ; Health Policy & Services
WOS IDWOS:000472670101294
Fulltext Access
Citation statistics
Cited Times [WOS]:0   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Affiliation1.University of Macau, Macau, Macao
2.Astrazeneca China, Beijing, China
First Author AffilicationUniversity of Macau
Recommended Citation
GB/T 7714
Lai, YF,Chen, SQ,Chen, PH,et al. DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY PHARMACIES IN CHINA: AN ANALYSIS OF CHEMICAL DRUGS[J]. VALUE IN HEALTH,2019,22(2):S175-S175.
APA Lai, YF,Chen, SQ,Chen, PH,Chen, XW,Ung, COL,&Hu, H.(2019).DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY PHARMACIES IN CHINA: AN ANALYSIS OF CHEMICAL DRUGS.VALUE IN HEALTH,22(2),S175-S175.
MLA Lai, YF,et al."DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY PHARMACIES IN CHINA: AN ANALYSIS OF CHEMICAL DRUGS".VALUE IN HEALTH 22.2(2019):S175-S175.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Lai, YF]'s Articles
[Chen, SQ]'s Articles
[Chen, PH]'s Articles
Baidu academic
Similar articles in Baidu academic
[Lai, YF]'s Articles
[Chen, SQ]'s Articles
[Chen, PH]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Lai, YF]'s Articles
[Chen, SQ]'s Articles
[Chen, PH]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.